Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Healthdyne Technologies developing fetal oximetry system, bilirubin test.

This article was originally published in The Gray Sheet

Executive Summary

HEALTHDYNE TECHNOLOGIES TO SUBMIT IDE FOR FETAL OXIMETRY SYSTEM within the next 30 days, company President and CEO Craig Reynolds said at the recent Robertson, Stephens & Company medical conference in New York City. The system, which provides "direct measurement of the oxygen status of the fetus," has been under development by Healthdyne for about two-and-a-half years.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel